Company Encyclopedia
View More
name
Douglasbay Capital
DBAY.UK
News
View More

Dbay Advisors Considers Takeover Proposal for Anexo Group

Dbay Advisors confirmed on Tuesday that it is considering making an offer for all the shares not already owned in Anexo Group . The asset management company said it is considering the proposal as a joint effort with Alan Sellers and Samantha Moss, noting that the offer will consist of loan notes issued through a newly incorporated, jointly owned entity. The potential offerors have until May 20 to confirm whether they will pursue a takeover offer for the London-listed specialist integrated credit hire and legal services provider.

Trading View·
UK
DBAY
0.00%
Trading View·
UK
DBAY
0.00%

Alliance Pharma agrees to £362m acquisition by DBAY

Alliance Pharma has accepted a £362m acquisition offer from DBAY Advisors, increasing the share price from 62.5p to 64.75p, a 3.6% rise. DBAY, which holds a 27.9% stake in Alliance, aims to implement operational changes away from public market pressures. Shareholders will vote on the proposal on 13 March 2025, with completion expected in the first half of 2025, transitioning Alliance to a privately owned entity. Alliance reported a revenue increase to £84m for the first half of 2024, with profit before tax rising to £12.7m.

Pharmaceutical Technology·
UK
DBAY
0.00%
Pharmaceutical Technology·
UK
DBAY
0.00%

Asset management firm DBAY to buy UK's Alliance Pharma in $430 million deal

Britain's Alliance Pharma has agreed to be acquired by DBAY Advisors for £349.7 million ($429.6 million) in an all-cash deal, representing a 41% premium over its previous stock price. The acquisition is expected to finalize in the first half of 2025, with the Alliance board recommending shareholders support the deal. Alliance Pharma, which distributes healthcare products globally, recently experienced a leadership change and reported a 23% increase in pre-tax profit for the first half of the year.

Reuters·
UK
DBAY
0.00%
Reuters·
UK
DBAY
0.00%